Intimation of Conference Call with Analysts and Investors.

Ref: Syn/CS/SE/Reg 30/2026-27/Jul/13 Syngene International Limited Biocon SEZ, Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area, IV Phase, Jigani Link Road, Bengaluru 560 099, Karnataka, India T +91 80 6891 9191 CIN: L85110KA1993PLC014937 July 22, 2026 www.syngeneintl.com To, To, The Manager, The Manager, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Corporate Communication Department Dalal Street, Mumbai – 400 001 Bandra (EAST), Mumbai – 400 051 Scrip Code: 539268 Scrip Symbol: SYNGENE Dear Sir/Madam, Subject: Intimation of Conference Call with Analysts and Investors Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the intimation for the conference call with Analysts and Investors to be held on Thursday, July 30, 2026. The above-mentioned information will also be available on the website of the Company www.syngeneintl.com. Request to kindly take this intimation on record. Thanking you, Yours faithfully, For SYNGENE INTERNATIONAL LIMITED Chethan Yogesh Company Secretary & Compliance Officer Encl: As above INVESTOR CONFERENCE CALL INVITE Q1 FY 2026-27 Syngene’s Q1 FY2027 Results Conference Call At 9:00 AM IST on 30th July 2026 The management team of Syngene International Limited (“Syngene”) will organize a conference call for Analysts and Investors on Thursday, 30th July 2026 at 9:00 AM IST following the announcement of financial results for the quarter ended June 2026. The call will be initiated with a brief management discussion on the Q1 FY2027 performance followed by an interactive Question & Answer session. Details of the conference call are as under: Date: Thursday, 30th July 2026 Time: 9:00 am to 10:00 am IST Dial-in Numbers* Primary Number +91 22 6280 1279 / 91 22 7115 8180 International Numbers USA – 18667462133 UK – 08081011573 Singapore – 8001012045 Hong Kong – 800964448 Australia – 0080014243444 Pre-registration Facility Step 1: Pre-register here . You will receive a passcode and a pin for the call on the registered email address. (Diamond Pass™ link) Step 2: Dial into the call on the Conference Call date, enter the passcode & pin as prompted. You will be directly connected to the call. *When using dial-in numbers mentioned please do so 10 minutes prior to the conference schedule to ensure that you are connected to your call in time Syngene International: Putting Science to Work Page 1 INVESTOR CONFERENCE CALL INVITE Q1 FY 2026-27 Participants can also join the webcast with https://event.choruscall.com/mediaframe/webcast.html?webcastid=edJ7ECjR the link: Replay/Audio Facility Dial in numbers: +91 22 71945757 Playback ID: 48209# The replay facility will be available from 30th July 2026 till 5th August 2026 The audio facility will also be available on the corporate website: https://syngeneintl.com/ Conference Call Transcript Will be available within 7 working days of the call on the corporate website. About Syngene Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE 398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene’s team of over 8,300 employees including 5,700+ scientists, brings both deep expertise and the capacity to deliver scientific excellence, robust data security, and world class manufacturing, at speed, to improve time-to market and lower the cost of innovation. With over 3 Mn sq. ft of specialized discovery, development, and manufacturing facilities across India and the U.S., Syngene works with ~400 global customers across industry segments, including biotech companies pursuing leading-edge science and multinationals such as BMS, GSK, Zoetis, and Merck KGaA. For more details, visit www.syngeneintl.com. For the Company’s latest Environmental, Social, and Governance (ESG) report, visit Syngene ESG Report. For further information, please contact: Nandini Agarwal / Ankush Balani P: +91 80 6891 9807 M: +91 7838382527 / 9163183180 E: nandini.agarwal@syngeneintl.com E: ankush.balani@syngeneintl.com Disclaimer: Certain of the statements that may be made or discussed at the conference call may be forward-looking statements and/or based on management's current expectations and beliefs concerning future developments and their potential effects upon Syngene International Limited (Syngene) and its associates. There can be no assurance that future developments affecting Syngene, and its associates will be those anticipated by management. These forward-looking statements are not a guarantee of future performance and involve risks and uncertainties and there are important factors that could cause actual results to differ, possibly materially, from expectations reflected in such forward-looking statements. Syngene does not intend, and is under no obligation, to update any forward-looking statement made at the conference call. Syngene International: Putting Science to Work Page 2